tiprankstipranks
Trending News
More News >
Entero Therapeutics (ENTO)
NASDAQ:ENTO
US Market
Advertisement

Entero Therapeutics (ENTO) Technical Analysis

Compare
1,310 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Entero Therapeutics’s (ENTO) Moving Averages Convergence Divergence (MACD) indicator is 0.28, suggesting Entero Therapeutics is a Sell.
Entero Therapeutics’s (ENTO) 20-Day exponential moving average is 2.09, while Entero Therapeutics’s (ENTO) share price is $2.77, making it a Buy.
Entero Therapeutics’s (ENTO) 50-Day exponential moving average is 1.77, while Entero Therapeutics’s (ENTO) share price is $2.77, making it a Buy.

Entero Therapeutics (ENTO) Pivot Points

Sep 05, 2025, 03:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.26
2.44
2.60
2.78
2.94
3.12
3.28
Fibonacci
2.44
2.57
2.65
2.78
2.91
2.99
3.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Entero Therapeutics (ENTO) Moving Averages

Sep 05, 2025, 03:58 PM
Period
Simple
Exponential
MA5
2.52Buy
2.53Buy
MA10
2.25Buy
2.33Buy
MA20
2.01Buy
2.09Buy
MA50
1.62Buy
1.77Buy
MA100
1.45Buy
1.60Buy
MA200
1.52Buy
1.56Buy
Entero Therapeutics’s (ENTO) 10-Day exponential moving average is 2.33, while Entero Therapeutics’s (ENTO) share price is $2.77, making it a Buy.
Entero Therapeutics’s (ENTO) 100-Day exponential moving average is 1.60, while Entero Therapeutics’s (ENTO) share price is $2.77, making it a Buy.
Entero Therapeutics’s (ENTO) stock price is $2.77 and Entero Therapeutics’s (ENTO) 50-day simple moving average is 1.62, creating a Buy signal.
Entero Therapeutics’s (ENTO) stock price is $2.77 and Entero Therapeutics’s (ENTO) 100-day simple moving average is 1.45, creating a Buy signal.
Entero Therapeutics’s (ENTO) stock price is $2.77 and Entero Therapeutics’s (ENTO) 200-day simple moving average is 1.52, creating a Buy signal.

Entero Therapeutics (ENTO) Technical Indicators

Sep 05, 2025, 03:58 PM
Name
Value
Implied Action
RSI (14)
70.60
Sell
STOCH (9,6)
82.92
Sell
STOCHRSI (14)
84.18
Sell
MACD (12,26)
0.28
Sell
ADX (14)
51.47
Sell
Williams %R
-23.02
Buy
CCI (14)
179.60
Sell
ATR (14)
0.29
-
Ultimate Oscillator
65.63
Neutral
ROC
44.02
Buy
Entero Therapeutics’s (ENTO) Relative Strength Index (RSI) is 70.60, creating a Sell signal.
Entero Therapeutics’s (ENTO) Trend Strength Indicator (ADX) is 51.47, creating a Sell signal.
Entero Therapeutics’s (ENTO) Commodity Channel Index (CCI) is 179.60, creating a Sell signal.
Entero Therapeutics’s (ENTO) Price Rate of Change (ROC) is 44.02, creating a Buy signal.

FAQ

Is ENTO a Buy, Hold, or Sell?
Based on ENTO’s technical indicators, ENTO is a Buy.
    What is ENTO’s RSI (14)?
    ENTO’s RSI (14) is 70.60, which suggests ENTO is a Sell.
      What is ENTO’s MACD?
      ENTO’s MACD is 0.28, which suggests ENTO is a Sell.
        What is ENTO’s 5-day moving average?
        ENTO’s 5-day moving average is 2.52, which suggests ENTO is a Buy.
          What is ENTO’s 20-day moving average?
          ENTO 20-day moving average is 2.01, which suggests ENTO is a Buy.
            What is ENTO’s 50-day moving average?
            ENTO’s 50-day moving average is 1.62, which suggests ENTO is a Buy.
              What is ENTO’s 200-day moving average?
              ENTO’s 200-day moving average is 1.52, which suggests ENTO is a Buy.
                What is ENTO’s Williams % R (14)?
                ENTO’s Williams % R (14) is -23.02, which suggests ENTO is a Buy.
                  What is ENTO’s CCI (14)?
                  ENTO’s CCI (14) is 179.60, which suggests ENTO is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis